ZYNE

Zynerba Pharmaceuticals, Inc. ZYNE

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ZYNE JUPW SXTC ACOR FLGC CLVR IMCC KHRNF ALID BFRI
6M 266.20 % 198.10 % -40.00 % -93.35 % -50.30 % -50.00 % -6.00 % 0.00 % -24.75 % 45.23 %
YTD 136.79 % 97.38 % -66.15 % -95.58 % -73.37 % -50.00 % -38.16 % 900.00 % -67.35 % -2.75 %
1Y 99.39 % 85.37 % -73.12 % -96.07 % -84.30 % -99.99 % -35.02 % 900.00 % -78.02 % 21.00 %
3Y -64.67 % -79.73 % -98.90 % -99.21 % -97.60 % -100.00 % -94.67 % -99.99 % -97.36 % -95.09 %
5Y -78.15 % -79.73 % -99.97 % -99.95 % -99.69 % -100.00 % -99.51 % -100.00 % -99.40 % -98.80 %
10Y -92.00 % -79.73 % -100.00 % -99.98 % -99.69 % -100.00 % -71.46 % -100.00 % -99.11 % -98.80 %
From the beginning -92.00 % -79.73 % -100.00 % -99.92 % -99.69 % -100.00 % -71.46 % -100.00 % -99.11 % -98.80 %

Dividend